SEC Form 4 · accession 0001013762-15-000791
DelMar Pharmaceuticals, Inc. · DMPI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis M Brown
Officer — Chief Scientific Officer · Director · 10% Owner
Period of report
Jul 25, 2015
Accepted (ET)
Jul 28, 2015 · 9:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001498382
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 25, 2015 | P | 10,000 | $0.60 | A | 3,037,542 | I | See Note |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants | $0.75 | Jul 25, 2015 | P | 10,000 | A | Jul 25, 2015 | Jul 25, 2020 | Common Stock | 10,000 | 85,000 | D |
Explanation of responses
- F1Includes 1,387,542 shares of the Issuer's common stock owned directly by Reporting Person and 1,650,000 shares of the Issuer's common stock held by Valent Technologies LLC, of which Reporting Person is the sole member and owner and holds sole voting and dispositive power over its shares..